Stephanie de Marco
Investor at Angels Santé
Stephanie De Marco
Investor at Angels Santé
France
Overview
Work Experience
Chief Executive Officer
2021 - Current
Chief Business Officer
2019 - 2021
After 15 years developing new businesses for big corps and 6 years investing in innovative startups, I have decided to combine both. I have invested in Sentinhealth and will work hard to fund and bring to the market an AI-powered device that will hopefully move heart failure patients from emergency care to homecare.
Startup Investor & Board Member
2013
Personal investments in 15 healthcare startups
President
2013 - 2019
Building the 1st private investor network dedicated to Healthcare in Europe. (100+ investors - 55 deals) Activity : Early-stage investment & business support for fast-growing companies. Scope : rounds of 500K-2.5 Mo€ in Biotech - Medtech - Diagnostics - Digital Health
Key Account Manager (hospitals & local payors - all divisions)
2012 - 2012
Kick-off of Abbott Pharmaceuticals multi-stakeholder strategy in the field
AbbVie is a pharmaceutical company that discovers, develops, and markets medicines.
Raised $15,000,249,999.00.
Sales Manager (primary care products)
2009 - 2011
Local execution of the European strategy: supporting sales & team transition in the French affiliate before restructuring
Commercial Director (primary care & hospital neonat)
2008 - 2009
Head of commercial strategy & operations in Primary Care & Immuno-Neonat (500+ people - $850Mo sales) Primary Care : Product life-cycle management and transition from Rx to OTC business and Restructuring plan in affiliates where OTC is not an option. Hospital Neonatology (immunotherapy): building a cross-functional business team to design & implement a new way-to-market in affiliates. Develop multi-stakeholder strategies directed to prescribers, distributors, patients, payors, politicians.
The Clara Abbott Foundation is a non-profit firm aimed to assist families, in gaining financial security for the rest of their lives.
Marketing Manager (all divisions)
2007 - 2007
Transition of 3M Pharma business to Meda
3M operates as a diversified technology company.
Raised $5,000,000.00 from US Department of Energy.
Franchise Manager (immunology)
2005 - 2006
Sales & Marketing Strategy in Europe. New product development with the global team.
Product Manager (dermatology/gynaecology)
2004 - 2005
Launch of 1st in-class immunostimulator in skin cancer & HPV across 27 countries.
3M operates as a diversified technology company.
Raised $5,000,000.00 from US Department of Energy.
Patient Communication Manager (all divisions)
2003 - 2003
Launch of 1st patient campaign against HPV across Europe.
3M operates as a diversified technology company.
Raised $5,000,000.00 from US Department of Energy.
Strategic Business Analyst (all divisions)
2001 - 2002
(3M corporate leadership program) Identification of new business opportunities for 3M Europe Board of Directors resulting in business unit openings and one global acquisition ($>1Bo). Consumer - Industrial - Healthcare Markets.
3M operates as a diversified technology company.
Raised $5,000,000.00 from US Department of Energy.
Junior Product Manager (consumer)
1999 - 2001
Launch of baby product range with KOLs in dermatology
Kimberly-Clark ranked among the top 10 World's Best Multinational Workplaces by Great Places to Work Institute for the third year in a row.